Monthly Archives: January 2012

Scientists Transform Skin Cells Direct To Brain Cells, Bypassing Stem Cell Stage

Featured Article Academic Journal Main Category: Stem Cell Research Also Included In: Neurology / Neuroscience;  Biology / Biochemistry Article Date: 31 Jan 2012 – 2:00 PST email to a friend   printer friendly   opinions   Current Article Ratings: Patient / Public: 5 (1 votes) Healthcare Prof: Bypassing the stem cell stage, researchers at the Stanford University School of Medicine in California converted mouse skin cells directly into neural precursor cells, the cells that go on to form the three main types of cell in the brain and nervous system. They write about their findings in the 30 January early online issue of the Proceedings of the National Academy of Sciences Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , , , | Comments Off

U.S. FDA approves new skin cancer medicine

The United States Food and Drug Administration (FDA) on Monday announced the approval of a drug to treat one of most common types of skin cancer. The FDA approved Erivedge (vismodegib), reviewed under the agency`s priority review program and ahead of the March 8 prescription user fee goal date, to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug, however, is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic) Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , | Comments Off

Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington …

Fibrocell Science, Inc. , a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announces that the June 2011 FDA approval of LAVIV™ for the improvement of the appearance of “smile line” wrinkles was named the #3 top story of 2011 in cell and gene therapy and regenerative medicine at The 2012 Cell & Gene Therapy Forum … Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , | Comments Off

FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that ErivedgeTM (vismodegib) capsule was approved by the U.S. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , , | Comments Off

Turning Basic Research into Better Treatments – Video


22-11-2011 13:27 The Myelin Repair Foundation (MRF) is changing the world of medical research, starting with developing a myelin repair therapeutic for multiple sclerosis faster than the status quo. In order to drive its basic research and translate it into faster, more successful treatments for patients, the MRF has launched its Translational Medicine Platform (TMP). This platform is essential for developing a successful myelin repair treatment for MS, and will help revolutionize the entire world of medical research Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , , , , , , , | Comments Off

Multiple sclerosis: BIIB’s Tysabri gets FDA O.K. on test, label change

Multiple sclerosis patients using Biogen Idec (NASDAQ:BIIB) drug Tysabri now have access to the first test that can help determine their risk for developing a rare but potentially fatal brain infection that affects some patients using the drug. The U.S. Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , , , , | Comments Off

MS drug prevented fatal heart condition in lab study

A drug used to treat multiple sclerosis may also be effective at preventing and reversing the leading cause of heart attack, a new study has found. Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , , , , | Comments Off

Multiple Sclerosis May Be Caused By A Virus

A new study that builds on previous research provides further evidence that multiple sclerosis may be caused by a viral infection. The suspected virus, the Epstein-Barr virus, is most commonly known as the cause of mono. Most people become infected with it at some point in their lives, often with no symptoms. Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , | Comments Off

Diabetic mice provide a surprising breakthrough for multiple sclerosis research

( American Friends of Tel Aviv University ) Dr. Dan Frenkel of Tel Aviv University has discovered that when mice with diabetes are injected with a specific protein, they experience the same brain lesions and disabilities that occur in human MS patients. Monitoring this brain lesion process through magnetic resonance imaging, Dr Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , , , | Comments Off

Expert: Multiple Sclerosis prevalent in Colorado

DENVER – Colorado has the highest rate of Multiple Sclerosis in the country. Wednesday morning, University of Colorado Hospital neurologists answered questions on the disease and why the MS rate is so high in Colorado. “There have been significant advances in the last few years about the cause of MS Continue reading

Posted in Multiple Sclerosis Research | Tagged , , , , , , , , , , , , , , | Comments Off